TP53 and acute myeloid leukemia: Importantly, the ability of MMRi62 to inhibit CFU was p53 independent, since IC50s for CFU inhibition were very similar with a value of ~12 μM for p53-wt and ~13 μM for p53-mutant AML patient samples (Figure S5).